A Shocking Disclosure on the MeSsy Podcast
Emmy-winning actor Christina Applegate has revealed that she does not have multiple sclerosis, more than five years after publicly sharing her initial diagnosis, according to The Guardian. Applegate made the announcement during an episode of her podcast MeSsy, which she co-hosts with fellow actor Jamie-Lynn Sigler. The revelation followed a seven-month hiatus from the program, during which Applegate processed new medical findings that completely upended her understanding of her chronic physical symptoms.
Applegate originally announced her multiple sclerosis diagnosis in 2021, leading her to step back from acting after wrapping up her role in the Netflix series Dead to Me. During her years living with the perceived condition, she became a prominent public advocate for chronic illness awareness, publishing an emotional memoir titled You With the Sad Eyes in March 2026. However, new medical testing prompted by unusual cell results revealed that the initial findings were incorrect. The actor described the moment she received the news, recalling her doctor entering the room and stating, “Congratulations — you don’t have MS.” Rather than bringing relief, the revelation left the 54-year-old actor feeling disoriented and distressed.
Returning to Square One Without Answers
“I’m back at square one — that I don’t know what’s going on with me,” she shared through tears on the podcast, as reported by Bustle. She emphasized that her physical condition has not improved, noting that she still experiences severe mobility challenges and requires a wheelchair when visiting medical offices. Applegate expressed deep emotional confusion regarding her advocacy work and her identity within the chronic illness community. Having spent years attributing her daily physical struggles to multiple sclerosis, she noted that losing that explanation left her feeling as though she had misled supporters. Sigler quickly reassured her co-host, stating that her dedicated advocacy and the support she provided to others remain meaningful regardless of the diagnostic update.
Applegate detailed the psychological toll of this transition, admitting, “It’s weird because I feel like I let everybody down. It’s this weird feeling of like I became this, you and I, the poster children for MS. All that I did, everything that I was doing, I had a reason as to why my day sucked every day. And now I don’t have a reason. It’s very unnerving and it’s really confusing for me.” Despite the lack of an MS diagnosis, she continues to suffer from the same neurological symptoms that led to her original 2021 assessment, including difficulty walking, fatigue, and muscle weakness.
Broader Medical Context and Diagnostic Challenges
The disclosure has drawn attention to the wider medical issue of multiple sclerosis misdiagnoses. During the podcast episode, Applegate and Sigler discussed the prevalence of diagnostic errors with medical professionals, including Dr. Marwa Kaisey, an associate professor at Cedars-Sinai Medical Center. Experts note that diagnosing multiple sclerosis relies on a complex set of clinical criteria rather than a single definitive test, which can lead to complications given that numerous conditions share overlapping symptoms. Dr. Kaisey explained that because there is no “pregnancy test” equivalent for MS, it remains a condition defined by a list of criteria that can be subjective and subject to change every several years.
Medical research underscores the scale of the issue. A 2024 Swiss-led study published in the Multiple Sclerosis Journal reported a 15% misdiagnosis rate among the cases examined, while other experts, such as Dr. Ilana Katz Sand of Mount Sinai, have suggested that in specialized clinics, the rate of misdiagnosis can be as high as 20%. These errors often occur when clinicians fail to properly identify “red flags” or misinterpret MRI findings that are not entirely typical for the disease. Patients frequently undergo unnecessary and intensive therapies, such as infusions, before the error is identified. Applegate noted that her medical team is now initiating a thorough, ongoing investigation to determine how the initial 2021 assessment occurred and what underlying medical issues may be causing her continuing symptoms. She remains in a state of shock, describing the situation as a “mindfuck” that has left her feeling hollow and scared as she begins the search for a new, accurate medical explanation.
The Path Forward for Chronic Illness Advocacy
The conversation between Applegate and Sigler serves as a reminder of the emotional weight carried by those who find identity and community through a specific diagnosis. For Applegate, the diagnosis had provided a framework for understanding her life-altering symptoms and a reason for her retirement from acting. The loss of that framework has created an existential crisis, forcing her to confront a reality where her symptoms are real, but their cause is currently unknown. Sigler, who has lived with relapsing multiple sclerosis since 2016, emphasized that Applegate’s contributions to the community remain valid, regardless of the label attached to her health journey. The episode serves as both a personal catharsis for the actor and a public education moment regarding the complexities of neurological diagnostic processes. As Applegate navigates this new uncertainty, her medical team has committed to an in-depth review of her health history since 2021, aiming to move beyond the false label and finally address the source of her physical decline. For now, the actor remains focused on processing the news while advocating for the necessity of second opinions and the ongoing need for more definitive diagnostic tools in neurology.